FB
JAZZ icon

Fulton Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

Fulton Bank’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,259
Closed -$337K – 411
2019
Q4 		$337K Sell
2,259
-40
-2% -$5.44K 0.02% 313
2019
Q3 		$295K Buy
2,299
+220
+11% +$29.5K 0.02% 324
2019
Q2 		$297K Sell
2,079
-55
-3% -$7.39K 0.02% 322
2019
Q1 		$305K Sell
2,134
-959
-31% -$125K 0.02% 315
2018
Q4 		$383K Sell
3,093
-354
-10% -$52.5K 0.03% 281
2018
Q3 		$580K Buy
3,447
+3
+0.1% +$516 0.04% 266
2018
Q2 		$593K Buy
3,444
+497
+17% +$81.2K 0.04% 248
2018
Q1 		$445K Buy
2,947
+45
+2% +$6.6K 0.03% 302
2017
Q4 		$391K Sell
2,902
-227
-7% -$31.5K 0.03% 319
2017
Q3 		$457K Buy
3,129
+332
+12% +$50.2K 0.03% 280
2017
Q2 		$435K Sell
2,797
-67
-2% -$10.2K 0.03% 272
2017
Q1 		$415K Sell
2,864
-60
-2% -$7.82K 0.03% 280
2016
Q4 		$319K Sell
2,924
-612
-17% -$68.2K 0.03% 327
2016
Q3 		$430K Buy
+3,536
New +$477K 0.04% 277

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fulton Bank's JAZZ Position: Q1 2020 in Review

Fulton Bank sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2020, closing a stake of 2,259 shares — an estimated $337K sold.

Fulton Bank first reported a position in JAZZ in Q3 2016 and held it in 14 quarters. The position peaked at $593K in Q2 2018. 407 funds tracked by Wall St. Rank hold JAZZ as of Q1 2020.

  • Fulton Bank reported no remaining Jazz Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Fulton Bank sold 2,259 Jazz Pharmaceuticals shares in Q1 2020, an estimated $337K.
  • Fulton Bank first reported a position in Jazz Pharmaceuticals in Q3 2016 and held it in 14 quarters.
  • Fulton Bank's Jazz Pharmaceuticals position peaked at $593K in Q2 2018.
  • 407 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2020.

Based on Fulton Bank's 13F filing for Q1 2020, filed 3 Apr 2020.